收官法兰，再启新程 | 京卫制药携手锐顺药业再度亮相CPHI Worldwide 2025

山东京卫制药有限公司携手子公司山东锐顺药业有限公司，再次盛装亮相此次行业盛会。全面展示公司在研发创新、精益生产与质量管理体系方面的最新成果。期间，展台吸引了众多专业观众驻足交流，现场气氛热烈。公司团队与来自全球的行业专家及合作伙伴深入探讨制药技术发展趋势与政策环境变化，进一步提升了京卫制药在国际市场的品牌影响力。

通过此次展会，京卫制药进一步巩固了与现有合作伙伴的紧密联系与业务协同，并与来自全球的多家潜在合作伙伴达成了明确的合作意向，拓宽了京卫制药国际商业领域在欧洲、美洲等严格法规市场的销售渠道。这些丰硕的洽谈成果，为公司国际业务版图的持续扩展奠定了更为坚实的基础。

公司致力于深化多元化合作模式，积极探索业务协同的新路径，旨在与全球伙伴构建起更为稳固、持久的共赢格局。同时，公司积极布局新兴市场，深度挖掘现有市场客户潜力，通过持续丰富产品管线，精准满足全球市场的多元化与个性化需求。

展望未来，京卫制药将始终坚持尽责、创新、追求卓越，坚定不移地致力于为全球客户提供更高质量、更可信赖的产品与服务。我们期待与更多志同道合的伙伴携手前行，在全球医药行业的广阔天地中，共同书写合作共赢的新篇章，为推进全球人类健康事业贡献更大的力量。

Jewim Pharma Successfully Attended the CPhI Worldwide 2025 in Frankfurt

From October 28 to 30, 2025, CPhI Worldwide 2025 was successfully held in Frankfurt, Germany, as the annual grand event it attracting global attention of the whole pharmaceutical industry. Under the theme of "Shaping Pharma’s Future", this exhibition witnessed an unprecedented grand occasion, gathering 2,400 exhibitors and approximately 62,000 professional visitors from 166 countries and regions. It has won active participation and wide recognition from practitioners in the global pharmaceutical and ingredients industry, marking the broadened scale and extensive influence in the global pharmaceutica-l and ingredients sector.

Jewim Pharmaceutical (Shandong) Co., Ltd., together with its subsidiary company Shandong Risen-Sun Pharm-aceutical Co., Ltd., made a stunning appearance at this event again with the fully demonstration of its latest achievements in R&D innovation, lean production and quality management system, which attracted a large number of professional visitors and gained lots of praise from them. The International business department of Jewim Pharma conducted in-depth discussions with the experts and partners on the development trends of pharmaceutical technology and changes in the policy environment, further enhancing the brand influence of Jewim in the international market.

Through this exhibition, Jewim Pharma has further consolidated the close ties and business synergy with existing partners and reached great cooperation intentions with a number of potential partners, expanding the company's sales channels in the internatio-nal business field, especially in the SRA markets such as European countries and the USA. That a more solid foundation for the continuous expansion of the company's international business landscape has been built.

Jewim is committed to deepening the diversified cooperation model and actively exploring new paths for business synergy. We aim to build a more stable and long-term win-win partnership with global partners. we are proactively expanding into emerging markets and intensifying efforts to unlock the potential of existing clients. By continuously enriching our product pipeline, we are dedicated to delivering products of superior quality and thoroughly satisfactory services.

In the future, Jewim Pharma will always adhere to the values of conscien-tious,creative and pursuit of excellence, and unswervingly dedicate itself to provid-ing higher-quality and more reliable products and services for global customers. We look forward to working hand in hand with partners to jointly create the win-win cooperations and contribute greater streng-th to promote the global health.